Is Cancer Research Being Blocked By Patents?

The ACLU just joined 20 plaintiffs – including the Public Patent Office – fighting to invalidate an exclusive patent on the genes associated with hereditary breast and ovarian cancer. The patent has given Myriad Genetics exclusive rights to diagnostic tests – which they sell for over $3,000 – plus control over the rights to even conduct experiments on these genes!

“Gene patents undermine the free exchange of information and scientific freedom,” argues the ACLU, saying the patents also compromise the integrity of our bodies and eventually our health.

Ultimately this case could answer the question of whether it’s legal to patent a gene…

, ,

21